Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,850 | 29,603 | 34,912 | 39,981 | 17,520 |
| Marketable Securities | N/A | N/A | 0 | 0 | 6,831 |
| Receivables | 1,571 | 102 | 15 | 630 | 559 |
| Other current assets | 848 | 623 | 0 | 0 | 0 |
| TOTAL | $30,633 | $33,382 | $38,173 | $45,337 | $30,995 |
| Non-Current Assets | |||||
| PPE Net | 1,436 | 1,368 | 647 | 752 | 744 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 227 |
| TOTAL | $1,436 | $1,368 | $647 | $752 | $971 |
| Total Assets | $32,069 | $34,750 | $38,820 | $46,089 | $31,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | N/A | 1,082 | 2,187 | 629 |
| Accrued Expenses | N/A | N/A | 2,490 | 2,349 | 1,736 |
| Other current liabilities | 1,259 | 314 | 532 | 5,291 | 153 |
| TOTAL | $6,137 | $4,103 | $4,237 | $10,018 | $2,651 |
| Non-Current Liabilities | |||||
| TOTAL | $7,621 | $7,678 | $7,020 | $7,053 | $7,076 |
| Total Liabilities | $13,758 | $11,781 | $11,257 | $17,071 | $9,727 |
| Shareholders' Equity | |||||
| Common Shares | 434,547 | 432,507 | 430,906 | 428,826 | 413,424 |
| Retained earnings | -460,153 | -452,897 | -446,003 | -442,054 | -432,129 |
| Other shareholders' equity | 722 | 670 | 544 | 655 | 554 |
| TOTAL | $18,311 | $22,969 | $27,563 | $29,018 | $22,239 |
| Total Liabilities And Equity | $32,069 | $34,750 | $38,820 | $46,089 | $31,966 |